Latest Articles

Management of athletes and active people with diabetes - The American Medical Society for Sports Medicine (AMSSM) scientific statement

iGlarLixi Enables Safe Ramadan Fasting for Most T2D Patients

New 2022 ADA/EASD Guidelines: GLPP-1 RA/Insulin Combination Is Recommended

ADA/EASD recommend considering combination injectables therapy of basal insulin/GLP-1 RA (Such as Soliqua^®) as valuable treatment option to provide adequate efficacy for achieving and maintaining glycemic goals.

Diabetes management during Ramadan

PCSK9 inhibitors and ACS

Lipid-lowering therapy and care gap in patients with Familial Hypercholesterolemia

Asthma Control Tests (ACT) overview

Saudi initiatives on Bronchiolitis Recommendations

The first choice of RSV prevention is Nirsevimab; alternatively, palivizumab is to be considered in case of unavailability of Nirsevimab.

The ROSETTE Study